Recommend Shingrix Instead of Zostavax II for Most Patients

The new zoster vaccine, Shingrix, will be preferred over Zostavax II...due to updated Canadian guidelines.

Give Shingrix starting at age 50...instead of 60. It seems to prevent shingles better than Zostavax II...and immunity may last longer.

About 37 patients need to receive Shingrix to prevent one case of shingles over 3 years...compared to about 59 with Zostavax. And both vaccines reduce the risk of postherpetic neuralgia.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote